PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 132 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,329,827 | -52.2% | 319,534 | -20.8% | 0.13% | -50.0% |
| Q2 2023 | $11,148,758 | +46.3% | 403,648 | +21.8% | 0.26% | +16.1% |
| Q1 2023 | $7,619,486 | +99.5% | 331,282 | -5.4% | 0.22% | +107.4% |
| Q4 2022 | $3,819,951 | +357.5% | 350,133 | +253.4% | 0.11% | +332.0% |
| Q3 2022 | $835,000 | +6.5% | 99,087 | -0.1% | 0.02% | +13.6% |
| Q2 2022 | $784,000 | -66.0% | 99,176 | +2.0% | 0.02% | -59.3% |
| Q1 2022 | $2,303,000 | -36.1% | 97,265 | -7.7% | 0.05% | -28.9% |
| Q4 2021 | $3,604,000 | +81.2% | 105,394 | -6.1% | 0.08% | +68.9% |
| Q3 2021 | $1,989,000 | -38.4% | 112,265 | +56.0% | 0.04% | -34.8% |
| Q2 2021 | $3,229,000 | +65.1% | 71,947 | -4.7% | 0.07% | +76.9% |
| Q1 2021 | $1,956,000 | – | 75,518 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |